Ετικέτες

Κυριακή 26 Φεβρουαρίου 2017

Patient Experience of Sentinel Lymph Node Biopsy for Melanoma

Sentinel lymph node biopsy (SLNB) has become an established investigation for assessing microscopic nodal metastasis in melanoma. In a 10-year review of SLNB for melanoma at a single institution, our unit reported a complication rate of 6%1. Despite the widespread use of SLNB for melanoma there are no studies that evaluate patient experience. A method of identifying this information is the study of patient reported outcome measures (PROMs), defined by the Food and Drug Administration as a "measurement of any aspect of a patient's health status that comes directly from the patient".

http://ift.tt/2mAZOqM

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αναζήτηση αυτού του ιστολογίου